tiprankstipranks
Belite Bio reports Q4 EPS (27c), consensus (30c)
PremiumThe FlyBelite Bio reports Q4 EPS (27c), consensus (30c)
1M ago
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
1M ago
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results
PremiumPress Releases
Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial Results
2M ago
Belite Bio receives approval for Phase 3 geographic atrophy trial in China
PremiumThe FlyBelite Bio receives approval for Phase 3 geographic atrophy trial in China
4M ago
Belite Bio initiated with bullish view at Maxim
PremiumThe Fly
Belite Bio initiated with bullish view at Maxim
4M ago
Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
PremiumPress Releases
Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference
5M ago
Belite Bio participates in a conference call with Cantor Fitzgerald
PremiumThe FlyBelite Bio participates in a conference call with Cantor Fitzgerald
6M ago
Belite Bio price target raised to $59 from $55 at H.C. Wainwright
PremiumThe Fly
Belite Bio price target raised to $59 from $55 at H.C. Wainwright
6M ago
Belite Bio presents results from a 24-month, Phase 2 study of Tinlarebant
PremiumThe Fly
Belite Bio presents results from a 24-month, Phase 2 study of Tinlarebant
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100